एपीए उद्धरण

Talreja, V. T., Noronha, V., Joshi, A., Patil, V., & Prabhash, K. (2020). An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast–ovarian cancer syndrome. South Asian J Cancer.

शिकागो स्टाइल उद्धरण

Talreja, Vikas T., Vanita Noronha, Amit Joshi, Vijay Patil, और Kumar Prabhash. "An Exceptional Response to Olaparib in Relapsed and Refractory BRCA2 Mutated Non-small Cell Lung Cancer in Hereditary Breast–ovarian Cancer Syndrome." South Asian J Cancer 2020.

एमएलए उद्धरण

Talreja, Vikas T., et al. "An Exceptional Response to Olaparib in Relapsed and Refractory BRCA2 Mutated Non-small Cell Lung Cancer in Hereditary Breast–ovarian Cancer Syndrome." South Asian J Cancer 2020.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.